# Labeling

Canada medical device licence | Worked example with fictional data

Step: Collect class-specific and quality evidence
Owner: Quality + clinical and technical leads
When: Before submission

## Gather first
- Approved intended use and indications
- Risk controls, warnings and test evidence
- Labeling rules, markets and device configuration

## How to prepare it
1. List the required label locations and formats for the product, packaging, instructions and software. Pull claims and warnings from the approved regulatory and risk files.
2. Check language, symbol, version and identification requirements in each market. Route clinical, usability and regulatory review and reconcile changes to the design.
3. Proof the production art or software screens, approve the exact version and retain a copy with the submission and release records.

## Example

### Label location
Device instructions for use

### Claim or control
Explain when a low-charge warning appears and what action the user should take.

### Supporting evidence
Approved intended use, risk control R-014 and usability review

### Version and market
IFU v3, applicable market and language versions listed

### Approval
Regulatory and quality approval before release

## Review
The production artifact agrees with the intended use and evidence. Warnings and symbols are consistent across channels.

## Handoff
Give the approved labeling files and control history to manufacturing, release and regulatory teams.

Use the current rules and any prescribed forms for your engagement.
